Glaucoma Unit, 1st University Department of Ophthalmology
Thessaloniki, 546 36, Greece
NCT Number: NCT01023997
The purpose of this study is to compare the central corneal thickness measurement in patients with exfoliation syndrome, exfoliative glaucoma, primary open-angle glaucoma, ocular hypertension and normal controls and to evaluate the value of corneal thickness in the diagnosis and management of glaucoma.
Looking for future studies?
Notify Me25 year–89 year
All sexes
Observational
Thessaloniki, 546 36, Greece
To compare the central corneal thickness measurement in patients with exfoliation, primary open-angle glaucoma, ocular hypertension and normal controls and to evaluate the value of corneal thickness in the diagnosis and management of glaucoma. Prospective study in progress. Randomly selected patients undergo a comprehensive ophthalmic exam which includes 2 separate pachymetry measurements in 2 different examinations at the same time of the day (10:00 am) with 3 different pachymeters. The values obtained are correlated with a number of other glaucoma parameters. A thinner cornea may represent a specific attribute and an additional risk factor for patients with exfoliation. Evaluation of corneal thickness is an important exam in the management of patients with exfoliation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Morning measurement (10:00-11:00)
Time frame: 10:00-11:00
Aristotle University Of Thessaloniki
Other
Central Corneal Thickness in Patients With Exfoliation Syndrome, Exfoliative Glaucoma, Exfoliative Glaucoma, Primary Open-angle Glaucoma and Ocular Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01936389
Exfoliation Syndrome, Eye Diseases
New York, United States
View Trial DetailsNCT00331240
Exfoliation Syndrome, Eye Diseases
Thessaloniki, Greece
View Trial DetailsNCT01022281
Exfoliation Syndrome, Eye Diseases
Thessaloniki, Greece
View Trial DetailsNCT01126203
Exfoliation Syndrome, Eye Diseases
Calgary, Alberta, Canada
View Trial Details